1 – 26 of 26
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer
(
- Contribution to journal › Article
-
Mark
A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers
(
- Contribution to journal › Article
-
Mark
Societal challenges of precision medicine : Bringing order to chaos
(
- Contribution to journal › Article
-
Mark
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
(
- Contribution to journal › Article
-
Mark
Somatic mutations reveal asymmetric cellular dynamics in the early human embryo
(
- Contribution to journal › Article
- 2016
-
Mark
Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer
(
- Contribution to journal › Scientific review
-
Mark
The advantage of laser-capture microdissection over whole tissue analysis in proteomic profiling studies
(
- Contribution to journal › Article
-
Mark
Targeted MS Assay Predicting Tamoxifen Resistance in Estrogen-Receptor-Positive Breast Cancer Tissues and Sera
(
- Contribution to journal › Article
-
Mark
Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer
(
- Contribution to journal › Article
-
Mark
4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer
(
- Contribution to journal › Article
-
Mark
Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients
(
- Contribution to journal › Article
-
Mark
The topography of mutational processes in breast cancer genomes
(
- Contribution to journal › Article
-
Mark
Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration
(
- Contribution to journal › Article
-
Mark
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
(
- Contribution to journal › Article
-
Mark
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
(
- Contribution to journal › Article
-
Mark
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer
(
- Contribution to journal › Article
- 2015
-
Mark
Global proteomic characterization of microdissected estrogen receptor positive breast tumors
(
- Contribution to journal › Article
-
Mark
Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells.
(
- Contribution to journal › Article
- 2014
-
Mark
Ferritin heavy chain in triple negative breast cancer : a favorable prognostic marker that relates to a cluster of differentiation 8 positive (CD8+) effector T-cell response
(
- Contribution to journal › Article
-
Mark
Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer
(
- Contribution to journal › Article
-
Mark
Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.
(
- Contribution to journal › Article
- 2013
-
Mark
Quantitative proteomic analysis of microdissected breast cancer tissues : comparison of label-free and SILAC-based quantification with shotgun, directed, and targeted MS approaches
(
- Contribution to journal › Article
-
Mark
Fine-Scale Mapping of the FGFR2 Breast Cancer Risk Locus: Putative Functional Variants Differentially Bind FOXA1 and E2F1
(
- Contribution to journal › Article
-
Mark
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
(
- Contribution to journal › Article
- 2012
-
Mark
Mutational Processes Molding the Genomes of 21 Breast Cancers
(
- Contribution to journal › Article
- 2010
-
Mark
Ancestry-Shift Refinement Mapping of the C6orf97-ESR1 Breast Cancer Susceptibility Locus
(
- Contribution to journal › Article